Evidence map›Paper›PMID 26059690›Full record

ArticleMuscle & nerve2016

Skeletal muscle ultrastructure and function in statin-tolerant individuals.

Jason L Rengo, Damien M Callahan, Patrick D Savage, Philip A Ades, Michael J Toth

Registry-linked trialAbstract read
In one paragraph

Article in Muscle & nerve, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01190046 (Muscle Disuse and Contractile Dysfunction in the Elderly), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01190046 nacompletednot on this map

Muscle Disuse and Contractile Dysfunction in the Elderly

TypeinterventionalSponsorUniversity of VermontRan2010 to 2016Enrolled35ConditionsOsteoarthritisArmsResistance exercise training
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jason L RengoDepartment of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA.
Damien M CallahanDepartment of Medicine, University of Vermont, College of Medicine, Burlington, Vermont, USA.
Patrick D SavageDepartment of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA.
Philip A AdesDepartment of Cardiology, University of Vermont Medical Center, Burlington, Vermont, USA.
Michael J TothDepartment of Medicine, University of Vermont, College of Medicine, Burlington, Vermont, USA.
University of Vermont Medical Center · USUniversity of Vermont · US

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KLEMPERER, ELIAS M · 2013 to 2022
$21.3M
POST-DOCTORAL CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007647 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI LEWINTER, MARTIN M · 1988 to 2013
$3.3M
Muscle disuse and contractile dysfunction in the elderlyR01AG033547 · NIA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TOTH, MICHAEL J · 2010 to 2014
$1.9M
Skeletal muscle contractile dysfunction in heart failureR01HL077418 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TOTH, MICHAEL J · 2006 to 2009
$1.5M
SKELETAL MUSCLE PROTEIN METABOLISM IN HEART FAILUREK01AR002125 · NIAMS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TOTH, MICHAEL J · 1999 to 2003
$444k
NHLBI NIH HHS HL-007647NHLBI NIH HHS R01 HL077418NHLBI NIH HHS T32 HL007647NIAMS NIH HHS K01 AR002125NIA NIH HHS R01 AG033547NIA NIH HHS R01-AG033547NIGMS NIH HHS P20 GM103644NIGMS NIH HHS P20GM103644
6 · The paper itself

Abstract

introductionStatins have well-known benefits on cardiovascular mortality, though up to 15% of patients experience side effects. With guidelines from the American Heart Association, American College of Cardiology, and American Diabetes Association expected to double the number of statin users, the overall incidence of myalgia and myopathy will increase.

methodsWe evaluated skeletal muscle structure and contractile function at the molecular, cellular, and whole tissue levels in 12 statin tolerant and 12 control subjects.

resultsMyosin isoform expression, fiber type distributions, single fiber maximal Ca(2+) -activated tension, and whole muscle contractile force were similar between groups. No differences were observed in myosin-actin cross-bridge kinetics in myosin heavy chain I or IIA fibers.

conclusionsWe found no evidence for statin-induced changes in muscle morphology at the molecular, cellular, or whole tissue levels. Collectively, our data show that chronic statin therapy in healthy asymptomatic individuals does not promote deleterious myofilament structural or functional adaptations.

Indexed as

ActinsAgedAged, 80 and overBody CompositionCohort StudiesCross-Sectional StudiesDose-Response Relationship, DrugFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsKneeMaleMuscle ContractionMuscle Fibers, SkeletalMuscle, SkeletalMyosin Heavy ChainsActinsHydroxymethylglutaryl-CoA Reductase InhibitorsMyosin Heavy Chainsmyalgiamyopathyskeletal musclestatinultrastructure

Identifiers

PMID26059690
PMCPMC4673037
OpenAlexW2157253731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.